Hemodynamic effects of acute administration of atomoxetine and methylphenidate.
Kelly
Ronan P
RP
Lilly-NUS Centre for Clinical Pharmacology, Level 6 Clinical Research Centre (MD11), National University of Singapore, Singapore.
Yeo
Kwee Poo
KP
Teng
Choo-Hua
CH
Smith
Brian P
BP
Lowe
Stephen
S
Soon
Danny
D
Read
Holly A
HA
Wise
Stephen D
SD
D018663:Adrenergic Agents / Q000494:pharmacology*; D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology*; D000328:Adult; D000069445:Atomoxetine Hydrochloride; D001794:Blood Pressure / Q000187:drug effects; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004837:Epinephrine / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000494:pharmacology*; D009638:Norepinephrine / Q000097:blood; D011437:Propylamines / Q000494:pharmacology*
D018663:Adrenergic Agents; D018759:Adrenergic Uptake Inhibitors; D011437:Propylamines; D008774:Methylphenidate; D000069445:Atomoxetine Hydrochloride; D009638:Norepinephrine; D004837:Epinephrine